Facts: Abstract: E904 Type: Eposter Presentat
Post# of 72440
(Total Views: 103)
Posted On: 06/28/2017 11:56:02 AM
Facts:
Abstract: E904
Type: Eposter Presentation
......
Conclusion
Our results suggest Kevetrin is a promising new drug in AML patients treatment, both in wild type and, even more, in TP53 mutated tumors, through different molecular mechanisms, giving more therapeutic alternatives in the treatment of this disease.
Session topic: 3. Acute myeloid leukemia - Biology
Abstract: E904
Type: Eposter Presentation
......
Conclusion
Our results suggest Kevetrin is a promising new drug in AML patients treatment, both in wild type and, even more, in TP53 mutated tumors, through different molecular mechanisms, giving more therapeutic alternatives in the treatment of this disease.
Session topic: 3. Acute myeloid leukemia - Biology
(2)
(1)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
If you try to defend yourself against lies of the board moderators your post will be deleted. Just like the board they claim to be better than!!! Watch who you trust especially the "long term investors" that support the real attackers!
Scroll down for more posts ▼